These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22390061)

  • 21. Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection.
    Tarchouna M; Ferjani A; Ben-Selma W; Boukadida J
    Int J Infect Dis; 2013 Jun; 17(6):e450-3. PubMed ID: 23510539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of fimbriated Escherichia coli in urinary tract infections in adult women: correlation with localization studies.
    Latham RH; Stamm WE
    J Infect Dis; 1984 Jun; 149(6):835-40. PubMed ID: 6145744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli.
    Tseng CC; Wu JJ; Liu HL; Sung JM; Huang JJ
    Am J Kidney Dis; 2002 Apr; 39(4):744-52. PubMed ID: 11920340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fimbriae as virulence factors of uropathogenic strains of Escherichia coli].
    Rytlewska M; Liberek A; Sikorska-Wisniewska G; Bako W
    Med Wieku Rozwoj; 2005; 9(4):743-52. PubMed ID: 16733282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance.
    Soto SM; Smithson A; Martinez JA; Horcajada JP; Mensa J; Vila J
    J Urol; 2007 Jan; 177(1):365-8. PubMed ID: 17162092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relation between P-fimbriae and resistance to amoxicillin, carbenicillin and tetracycline in uropathogenic strains of Escherichia coli].
    Vranes J; Schönwald S; Zagar Z
    Lijec Vjesn; 1994; 116(7-8):178-81. PubMed ID: 7853994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of virulence genes of E. coli strains isolated from children with urinary tract infection.
    Farshad S; Emamghorashi F
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):613-7. PubMed ID: 19587502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are quinolone-resistant uropathogenic Escherichia coli less virulent?
    Vila J; Simon K; Ruiz J; Horcajada JP; Velasco M; Barranco M; Moreno A; Mensa J
    J Infect Dis; 2002 Oct; 186(7):1039-42. PubMed ID: 12232848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of fimbriae of Escherichia coli in urinary tract infections].
    Ishikawa S
    Hinyokika Kiyo; 1991 Sep; 37(9):953-6. PubMed ID: 1686148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urinary tract infections and their prevention].
    González-Chamorro F; Palacios R; Alcover J; Campos J; Borrego F; Dámaso D
    Actas Urol Esp; 2012 Jan; 36(1):48-53. PubMed ID: 21757260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of pili in the adhesion of Escherichia coli to human urinary tract epithelial cells.
    Korhonen TK; Väisänen V; Kallio P; Nurmiaho-Lassila EL; Ranta H; Siitonen A; Elo J; Svenson SB; Svanborg-Edén C
    Scand J Infect Dis Suppl; 1982; 33():26-31. PubMed ID: 6127801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo dynamics of type 1 fimbria regulation in uropathogenic Escherichia coli during experimental urinary tract infection.
    Gunther NW; Lockatell V; Johnson DE; Mobley HL
    Infect Immun; 2001 May; 69(5):2838-46. PubMed ID: 11292696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pap, papG and prsG DNA sequences in Escherichia coli from the fecal flora and the urinary tract.
    Johanson IM; Plos K; Marklund BI; Svanborg C
    Microb Pathog; 1993 Aug; 15(2):121-9. PubMed ID: 7902954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical characteristic of biofilm of uropathogenic Escherichia coli Dr(+) strains.
    Zalewska-Piątek B; Wilkanowicz S; Bruździak P; Piątek R; Kur J
    Microbiol Res; 2013 Jul; 168(6):367-378. PubMed ID: 23375236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection.
    Kalas V; Hibbing ME; Maddirala AR; Chugani R; Pinkner JS; Mydock-McGrane LK; Conover MS; Janetka JW; Hultgren SJ
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2819-E2828. PubMed ID: 29507247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycosylation changes as important factors for the susceptibility to urinary tract infection.
    Taganna J; de Boer AR; Wuhrer M; Bouckaert J
    Biochem Soc Trans; 2011 Jan; 39(1):349-54. PubMed ID: 21265802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of virulence variations on MDCK monolayers by Escherichia coli isolated from acute lobar nephronia and acute pyelonephritis.
    Cheng CH; Su LH; Tsau YK; Lin TY
    New Microbiol; 2011 Jan; 34(1):65-72. PubMed ID: 21344148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis.
    Guglietta A
    Future Microbiol; 2017 Mar; 12():239-246. PubMed ID: 28262045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation of Escherichia coli strains associated with canine urinary tract infections.
    Westerlund B; Pere A; Korhonen TK; Jarvinen AK; Siitonen A; Williams PH
    Res Vet Sci; 1987 May; 42(3):404-6. PubMed ID: 2887017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.